0001144204-19-031915.txt : 20190621
0001144204-19-031915.hdr.sgml : 20190621
20190621170121
ACCESSION NUMBER: 0001144204-19-031915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190620
FILED AS OF DATE: 20190621
DATE AS OF CHANGE: 20190621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: He Wei-Wu
CENTRAL INDEX KEY: 0001542073
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20713
FILM NUMBER: 19912243
MAIL ADDRESS:
STREET 1: ENTREMED, INC.
STREET 2: 9640 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0000895051
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 581959440
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-864-2600
MAIL ADDRESS:
STREET 1: 9620 MEDICAL CENTER DR
STREET 2: STE 300
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ENTREMED INC
DATE OF NAME CHANGE: 19960415
4
1
tv524053_4.xml
OWNERSHIP DOCUMENT
X0306
4
2019-06-20
0
0000895051
CASI Pharmaceuticals, Inc.
CASI
0001542073
He Wei-Wu
CASI PHARMACEUTICALS, INC.
9620 MEDICAL CENTER DR. SUITE 300
ROCKVILLE
MD
20850
1
1
1
0
CEO
Stock Option (Right to Buy)
2.85
2019-06-20
4
A
0
4000000
0
A
2021-04-02
2029-04-02
Common Stock
4000000
4000000
D
The option grant was approved by the Board of Directors effective April 2, 2019, subject to stockholder approval of the option grant. The Company's stockholders approved the option grant on June 20, 2019. All of the options will vest and become exercisable the earlier of (i) completion of a transformative event by the Company as determined in the discretion of the Compensation Committee or (ii) the second anniversary of the date of grant.
/s/Cynthia W. Hu, attorney-in-fact for We-Wu He
2019-06-21